그래디언트
035080KOSDAQ61.8 / 100
Reference Date: 2026-09-08
Company InformationBased on 2025 Annual Report
Business Overview
Gradient operates four business segments: holding company operations, B2B e-commerce, bio-healthcare, and others. The e-commerce division contributes approximately 75% of total revenue, while the bio-healthcare segment focuses on pharmaceuticals and medical product development. The holding company segment manages and supports subsidiaries.
Number of Employees
62people
Average Salary
71.3M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Well below industry avg
Half of industry avg (excellent)
Avg ▼5.4% (2-year basis)
Avg ▼363.0% (2-year basis)
Avg ROE -2.4% (declining, 3yr)
Detailed News Sentiment
- Negative'다중 AI 에이전트' 위협 현실로, 편의 좇다 통제 불능
AI 에이전트의 자율성 증가로 인한 통제 불능 위험이 그래디언트 주식에 부정적 영향을 미침.
- Positive그래디언트, 100억 규모 자사주 취득 신탁계약 체결 결정
그래디언트가 NH투자증권과의 계약을 통해 자사주 취득 신탁을 체결함으로써 주가 안정화와 주주가치 향상에 긍정적 영향을 미칠 것으로 예상된다.
Detailed Momentum
52w mid range (57%)
1m +19.64% (strong rise)
Volume dry-up
Detailed Disclosure
- Neutral반기보고서 (2026.06)2026-08-14
- Neutral주식소각결정2026-08-10
- Positive주요사항보고서(자기주식취득신탁계약체결결정)2026-08-10
